Previous 10 | Next 10 |
GT Biopharma to Present at Raymond James Human Health Innovation Conference PR Newswire BEVERLY HILLS, Calif., June 16, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused...
Cold Chain Technologies Announces Further Global Expansion Into Latin America Cold Chain Technologies Is Ready to Offer its 50 Years of Experience to the Life Sciences Industry in Latin America PR Newswire FRANKLIN, Mass. , June 16, 2021 /PRNewswire/ -- Cold ...
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline Proceeds will enable further clinical development of DSP107, a first-in-class CD47x41BB targeting fusion protein, for the treatment of solid and hematological tumors and accelerate t...
Elanco Announces Agreement to Acquire Kindred Biosciences Bolt-on Acquisition Accelerates Elanco's Expansion in Pet Health Elanco to host conference call for investment community at 8:00 am Eastern Time -- Elanco will acquire all outstanding stock of Kindred Biosciences ...
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services PR Newswire SHANGHAI , June 16, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering onl...
United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review FDA action expected in October 2021 PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , June 16, 2021 /PRNewswire/ -- United Therapeu...
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment PR Newswire CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China , June 15, 2021 /PRNewswire/ -- Harbour BioMed (HKEX: 0...
Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform Financing led by Casdin Capital, Sofinnova Partners - initial seed investor, and an undisclosed investor Mnemo delivers epigenetic antige...
Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci The combination of the Totient technology with AbSci's platform provides the framework and data to enable in silico targeted drug design, and ultimately achieve the goals of making the best medicines available...
Protagonist Therapeutics Announces Pricing of $115 Million Upsized Public Offering of Common Stock PR Newswire NEWARK, Calif., June 15, 2021 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX), a clinical stage biopharmaceutical company, today announce...
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024. ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferi...
2024-05-09 12:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...